Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 2,134,000 | 10,081,000 | 4,506,000 | 3,031,000 | 2,934,000 |
Marketable Securities | 33,212,000 | 22,318,000 | 18,462,000 | 21,275,000 | 21,038,000 |
Receivables | 12,735,000 | 10,675,000 | 12,523,000 | 12,882,000 | 14,182,000 |
Inventories | 7,035,000 | 6,076,000 | 7,516,000 | 7,001,000 | 7,189,000 |
Income taxes - deferred | N/A | 6,170,000 | N/A | N/A | N/A |
Other current assets | 9,647,000 | 9,511,000 | 14,120,000 | 14,576,000 | 9,520,000 |
TOTAL | $64,763,000 | $64,831,000 | $57,127,000 | $58,765,000 | $54,863,000 |
Non-Current Assets | |||||
PPE Net | 13,950,000 | 13,213,000 | 14,606,000 | 14,756,000 | 16,192,000 |
Investments And Advances | 15,392,000 | 14,149,000 | 13,429,000 | 10,548,000 | 10,632,000 |
Intangibles | 87,861,000 | 88,807,000 | 91,579,000 | 92,967,000 | 98,053,000 |
Other Non-Current Assets | 5,432,000 | 4,798,000 | 5,862,000 | 5,806,000 | 5,943,000 |
TOTAL | $122,635,000 | $120,967,000 | $125,476,000 | $124,077,000 | $130,820,000 |
Total Assets | $187,398,000 | $185,798,000 | $182,603,000 | $182,842,000 | $185,683,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 8,896,000 | 6,424,000 | 7,774,000 | 7,703,000 | 5,526,000 |
Accounts payable and accrued liabilities | 3,279,000 | 2,921,000 | 2,967,000 | 3,165,000 | 3,091,000 |
Accrued Expenses | 1,684,000 | 1,875,000 | 1,736,000 | 1,493,000 | 1,752,000 |
Other current liabilities | 12,521,000 | 13,812,000 | 13,455,000 | 13,215,000 | 14,794,000 |
TOTAL | $27,543,000 | $29,186,000 | $29,131,000 | $30,798,000 | $27,094,000 |
Non-Current Liabilities | |||||
Long Term Debt | 31,481,000 | 31,036,000 | 31,083,000 | 30,868,000 | 33,543,000 |
Other Non-Current Liabilities | 23,087,000 | 22,699,000 | 21,135,000 | 22,721,000 | 21,621,000 |
TOTAL | $77,028,000 | $74,934,000 | $71,357,000 | $72,083,000 | $74,912,000 |
Total Liabilities | $104,571,000 | $104,120,000 | $100,488,000 | $102,881,000 | $102,006,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 7,093,223 | 7,189,062 | 7,362,573 | 7,469,484 | 7,488,136 |
Common Shares | 450,000 | 448,000 | 447,000 | 447,000 | 446,000 |
Retained earnings | 56,972,000 | 54,240,000 | 51,256,000 | 47,904,000 | 48,124,000 |
Other shareholders' equity | -5,541,000 | -5,496,000 | -5,202,000 | -5,554,000 | -3,160,000 |
TOTAL | $82,827,000 | $81,678,000 | $82,115,000 | $79,961,000 | $83,677,000 |
Total Liabilities And Equity | $187,398,000 | $185,798,000 | $182,603,000 | $182,842,000 | $185,683,000 |